TriSalus Life Sciences
TLSI
79 hedge funds and large institutions have $99M invested in TriSalus Life Sciences in 2026 Q2 according to their latest regulatory filings, with 12 funds opening new positions, 45 increasing their positions, 10 reducing their positions, and 15 closing their positions.
350% more repeat investments, than reductions
Existing positions increased: 45 | Existing positions reduced: 10
19% more capital invested
Capital invested by funds: $83.4M → $99M (+$15.6M)
1.41% more ownership
Funds ownership: 34.02% → 35.43% (+1.4%)
0% more funds holding in top 10
Funds holding in top 10: 1 → 1 (0)
6% less funds holding
Funds holding: 84 → 79 (-5)
20% less first-time investments, than exits
New positions opened: 12 | Existing positions closed: 15
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
FLAM
First Light Asset Management
Edina,
Minnesota
|
+$5.9M |
| 2 |
BlackRock
New York
|
+$4.61M |
| 3 |
Cerity Partners
New York
|
+$3.24M |
| 4 |
Geode Capital Management
Boston,
Massachusetts
|
+$1.64M |
| 5 |
Vanguard Capital Management
Malvern,
Pennsylvania
|
+$1.52M |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
AIC
AWM Investment Company
New York
|
-$8.32M |
| 2 |
WA
Wasatch Advisors
Salt Lake City,
Utah
|
-$5.75M |
| 3 |
NCM
Nantahala Capital Management
New Canaan,
Connecticut
|
-$4.25M |
| 4 |
EFMC
Empire Financial Management Company
New York
|
-$1.2M |
| 5 |
ACA
Apis Capital Advisors
New York
|
-$720K |
TLSI Hedge Fund Activity: Q2 2026 in Review
79 of the 8,318 institutional investors tracked by Wall St. Rank reported a position in TriSalus Life Sciences (TLSI) for Q2 2026, worth a combined $99M — up 19% from $83.4M a quarter earlier.
Sellers outnumbered buyers: 15 funds closed out of TLSI and 12 opened new positions — a net loss of 3 holders — while 10 trimmed existing stakes and 45 added.
The largest buyer was First Light Asset Management, adding an estimated $5.9M. The largest seller was AWM Investment Company, exiting entirely with an estimated $8.32M sold.
- 79 institutional investors held TriSalus Life Sciences (TLSI) as of Q2 2026, down from 84 in Q1 2026.
- Funds reported $99M of TriSalus Life Sciences stock for Q2 2026, up 19% quarter-over-quarter.
- 12 funds opened new TriSalus Life Sciences positions in Q2 2026 and 15 closed out, a net change of -3 holders.
- The largest TriSalus Life Sciences buyer in Q2 2026 was First Light Asset Management, an estimated $5.9M added.
- The largest TriSalus Life Sciences seller in Q2 2026 was AWM Investment Company, an estimated $8.32M sold.
Based on aggregated 13F filings for Q2 2026.